Eifelhöhen-Klinik AG (EIF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Eifelhöhen-Klinik AG (EIF) has a cash flow conversion efficiency ratio of -0.004x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-34.00K ≈ $-39.75K USD) by net assets (€9.34 Million ≈ $10.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Eifelhöhen-Klinik AG (EIF) net asset quality to measure how much of total assets are equity-financed.
Eifelhöhen-Klinik AG - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Eifelhöhen-Klinik AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Eifelhöhen-Klinik AG to evaluate the quality of earnings relative to operating cash generation.
Eifelhöhen-Klinik AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eifelhöhen-Klinik AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
VistaGen Therapeutics Inc
NASDAQ:VTGN
|
-0.456x |
|
The European Smaller Companies Trust PLC
LSE:ESCT
|
-0.003x |
|
Automobile &Pc
KO:015260
|
0.067x |
|
Pinnacle Food Group Limited Class A Common Shares
NASDAQ:PFAI
|
N/A |
|
Trencor
JSE:TRE
|
0.000x |
|
Warisan TC Holdings Bhd
KLSE:5016
|
0.007x |
|
Megado Minerals Ltd
AU:MEG
|
-0.069x |
|
Logismos Information Systems S.A
AT:LOGISMOS
|
0.026x |
Annual Cash Flow Conversion Efficiency for Eifelhöhen-Klinik AG (2013–2024)
The table below shows the annual cash flow conversion efficiency of Eifelhöhen-Klinik AG from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see EIF market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €12.61 Million ≈ $14.74 Million |
€2.31 Million ≈ $2.70 Million |
0.183x | +135.27% |
| 2023-12-31 | €12.71 Million ≈ $14.86 Million |
€991.00K ≈ $1.16 Million |
0.078x | +126777.12% |
| 2022-12-31 | €9.88 Million ≈ $11.55 Million |
€607.00 ≈ $709.65 |
0.000x | -99.98% |
| 2021-12-31 | €10.81 Million ≈ $12.63 Million |
€3.63 Million ≈ $4.25 Million |
0.336x | +5.49% |
| 2020-12-31 | €14.93 Million ≈ $17.45 Million |
€4.76 Million ≈ $5.56 Million |
0.319x | +77.08% |
| 2019-12-31 | €16.65 Million ≈ $19.47 Million |
€3.00 Million ≈ $3.50 Million |
0.180x | +843.51% |
| 2018-12-31 | €16.30 Million ≈ $19.05 Million |
€311.00K ≈ $363.59K |
0.019x | -84.85% |
| 2017-12-31 | €17.70 Million ≈ $20.70 Million |
€2.23 Million ≈ $2.61 Million |
0.126x | +96.65% |
| 2016-12-31 | €18.66 Million ≈ $21.81 Million |
€1.19 Million ≈ $1.40 Million |
0.064x | -27.16% |
| 2015-12-31 | €14.69 Million ≈ $17.18 Million |
€1.29 Million ≈ $1.51 Million |
0.088x | -69.20% |
| 2014-12-31 | €15.00 Million ≈ $17.53 Million |
€4.28 Million ≈ $5.00 Million |
0.285x | +50.82% |
| 2013-12-31 | €16.98 Million ≈ $19.85 Million |
€3.21 Million ≈ $3.76 Million |
0.189x | -- |
About Eifelhöhen-Klinik AG
MedNation AG operates facilities for outpatient and inpatient orthopedics, geriatrics, and internal medicine in Germany. The company is also involved in specialist clinic for cardiological rehabilitation. In addition, it operates specialist clinic with indications for neurology and orthopedics, as well as medical care, nursing, and inpatient care facilities. The company was formerly known as Eife… Read more